Increased expression of miRNA-182 in colorectal carcinoma: An independent and tissue-speciic prognostic factor

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 6, 2014, Pages 3498-3503

  Wang, Shuang ^a   Yang, Min Hui ^a   Wang, Xiao Yan ^a   Lin, Jie ^a   Ding, Yan Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; In situ hybridization; miR 182; Prognosis

Indexed keywords

MICRORNA; MIRN182 MICRORNA, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; BIOSYNTHESIS; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84904310607     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43
2. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer. Lancet 2005; 365: 153-65
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97
4. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7
5. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentia-tion. Science 2004; 303: 83-6
6. Ahmed FE, Jeffries CD, Vos PW, Flake G, Nuovo GJ, Naziri W, Marcuard SP. Diagnostic microR-NA markers for screening sporadic human co-lon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics 2009; 6: 281-95
7. Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T. Clinicopathological and prognos-tic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010; 79: 313-20
8. Tchernitsa O, Kasajima A, Schafer R, Kuban RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert MP, Röcken C. Systematic evaluation of the miRNA-ome and its down-stream effects on mRNA expression identiies gastric cancer progression. J Pathol 2010; 222: 310-9.
9. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol 2012; 228: 204-15
10. Liu H, Du L, Wen Z, Yang Y, Li J, Wang L, Zhang X, Liu Y, Dong Z, Li W, Zheng G, Wang C. Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value. Int J Colorectal Dis 2013; 28: 697-703
11. Lei R, Tang J, Zhuang X, Deng R, Li G, Yu J, Li-ang Y, Xiao J, Wang HY, Yang Q, Hu G. Suppres-sion of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Onco-gene 2014; 33: 1287-96
12. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009; 284: 23204-16
13. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Her-nando E. Aberrant miR-182 expression pro-motes melanoma metastasis by repressing FOXO3 and microphthalmia-associated tran-scription factor. Proc Natl Acad Sci U S A 2009; 106: 1814-9
14. Huynh C, Segura MF, Gaziel-Sovran A, Menen-dez S, Darvishian F, Chiriboga L, Levin B, Meruelo D, Osman I, Zavadil J, Marcusson EG, Hernando E. Eficient in vivo microRNA target-ing of liver metastasis. Oncogene 2011; 30: 1481-8
15. Cekaite L, Rantala JK, Bruun J, Guriby M, Age-sen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI. MiR-9, -31, and -182 deregulation promote prolifera-tion and tumor cell survival in colon cancer Neoplasia 2012; 14: 868-79
16. Ma Q, Yang L, Wang C, Yu YY, Zhou B, Zhou ZG. Differential expression of colon cancer microR-NA in microarry study. Sichuan Da Xue Xue Bao Yi Xue Ban 2011; 42: 344-8
17. Yang MH, Yu J, Chen N, Wang XY, Liu XY, Wang S, Ding YQ. Elevated microRNA-31 expression regulates colorectal cancer progression by re-pressing its target gene SATB2. PLoS One 2013; 8: e85353
18. Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT. Independent and tissue-speciic prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A pre-dicts poor survival. Cancer 2011; 117: 3193-200
19. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M, Sugihara K. Cyclooxygenase-2 ex-pression: a signiicant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004; 10: 8465-71
20. Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, Gorospe M, Harris AL, Helleday T, Chowdhury D. miR-182-mediated downregulation of BRCA1 im-pacts DNA repair and sensitivity to PARP in-hibitors. Mol Cell 2011; 41: 210-20
21. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, Ju J. Systematic analysis of microR-NA expression of RNA extracted from fresh fro-zen and formalin-ixed parafin-embedded samples. RNA 2007; 13: 1668-74
22. Jiang L, Mao P, Song L, Wu J, Huang J, Lin C, Yuan J, Qu L, Cheng SY, Li J. miR-182 as a prog-nostic marker for glioma progression and pa-tient survival. Am J Pathol 2010; 177: 29-38
23. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. Prognos-tic signiicance of differentially expressed miR-NAs in esophageal cancer. Int J Cancer 2011; 128: 132-43
24. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J. The role of miR-31 and its target gene SATB2 in cancer-associat-ed ibroblasts. Cell Cycle 2010; 9: 4387-98.